126840-28-6 | 4-HYDROXYDIPHENYL-D9 |
126840-35-5 | 4-N-PENTYLDIPHENYL-D20 |
126840-36-6 | 1-BROMOOCTANE-D17 |
126844-81-3 | nagstatin |
126849-31-8 | 2-Amino-3-benzoyl-α-oxo-benzeneacetic Acid Sodium Salt |
126849-95-4 | BAKERBOND(TM) OCTYL (C8) |
126849-96-5 | PHENYL (C6H5) NARROW-PORE MEDIA-REVERSE PHASE |
126850-01-9 | WP BUTYL (C4) REVERSE PHASE MEDIA |
126850-03-1 | BAKERBOND(TM) CYANO (CN) |
126850-04-2 | BAKERBOND(TM) DIOL (COHCOH) |
126850-05-3 | AMINO (NH2) NARROW-PORE MEDIA-NORMAL PHASE |
126850-06-4 | WP QUAT (STRONG ANION EXCHANGER) |
126850-07-5 | WP PEI (WEAK ANION EXCHANGER) |
126850-08-6 | ABX (ANTIBODY EXCHANGER) |
126850-10-0 | WP HI-PROPYL (C3) MEDIA |
126850-11-1 | WP CARBOXY-SULFON (WEAK-STRONG CATION EXCHANGER) |
126850-15-5 | BAKERBOND(TM) CARBOXYLIC ACID (COOH) |
126850-16-6 | AROMATIC SULFONIC ACID (C6H5SO3H) NARROW-PORE MEDIA-ION EXCHANGE |
126850-17-7 | PROPYL SULFONIC ACID (SO3H) NARROW-PORE MEDIA-ION EXCHANGE |
126851-39-6 | ACID BROWN 422 |
126851-40-9 | Acid brown 434 |
126854-10-2 | N(2),3-ethanoguanine |
126856-30-2 | Pyridine, 5-chloro-2-[(trimethylsilyl)oxy]- (9CI) |
126856-32-4 | 4-[(2,6-Dichlorophenyl)iMino]tetrahydro-3-thiophenecarboxylic Acid Methyl Ester |
126856-34-6 | 3-Thiophenecarboxylicacid,tetrahydro-4-oxo-(9CI) |
126857-69-0 | LUTETIUM(III) TRIFLUOROMETHANESULFONATE |
126857-76-9 | N-(9-acridinyl)bromoacetamide |
126857-81-6 | ethyl 3-(2,2,5,5-tetramethylpyrrollinyl-1-oxyl)propen-2-oate |
126860-83-1 | (5Z,7E,22E)-9,10-Seco-26,27-cyclo-1α,3β-dihydroxycholesta-5,7,10(19),22-tetren-24-one |
126860-84-2 | (5Z,7E)-9,10-Seco-26,27-cyclo-1α,3β-dihydroxycholesta-5,7,10(19)-trien-24-one |
126860-97-7 | (1-Methyloctyl)magnesium bromide |
126861-72-1 | 2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine |
126862-95-1 | 3'-thiothymidine |
126863-12-5 | 2-Pyrrolidinone, 3-acetyl-1,3-dimethyl-4-methylene- (9CI) |
126863-75-0 | 3-(2,3-dihydroxypropyl)deoxyuridine |
126865-08-5 | Benzenesulfonic acid, 3-Methyl-, ethyl ester |
126865-27-8 | 1H-Pyrazole-4-carboxylicacid,3-amino-5-(2-hydroxyethoxy)-,methylester(9CI) |
126865-31-4 | 4-Isoxazolecarboxylicacid,5-amino-3-(2-hydroxyethoxy)-,methylester(9CI) |
126865-37-0 | 2-AMINO-4-(2-HYDROXYETHOXY)-6-OXO-1,6-DIHYDRO-5-PYRIMIDINECARBONITRILE |
126866-15-7 | 1-(4-Chlorophenyl)-2-(4-fluorophenyl)ethanone |
126866-16-8 | 2-(4-Chlorophenyl)-1-(4-fluorophenyl)ethanone |
126866-34-0 | 5'-Chloro-1,1':3',1''-terphenyl |
126866-35-1 | 3-bromo-5-chlorobiphenyl |
126866-37-3 | 2-AMINO-N-METHYL-N-PHENYL-ACETAMIDE |
126869-04-3 | 5,6-DIMETHYL-2-[4-[3-(1-PIPERIDINOMETHYL)PHENOXY]-(Z)-2-BUTENYLAMINO]-4(1H)-PYRIMIDONE DIHYDROCHLORIDE |
126869-27-0 | 7-forskolinyl-2-(3-azido-5-hydroxy-4-iodophenoxy)acetate |
126869-52-1 | RM 06 |
126871-92-9 | N(epsilon)-(diazotrifluoroethyl)benzoyl-Lys(8)-cyclosporin |
126872-00-2 | N-FORMYL-DL-ETHIONINE |
126872-16-0 | alpha-Ribofuranose (9CI) |
126872-94-4 | (S)-2-HYDROXYMETHYL-PIPERAZINE |
126874-79-1 | 2-methoxyapomorphine |
126874-82-6 | 2-methoxy-N-n-propylnorapomorphine |
126875-53-4 | 1,13-DIOXA-4,7,10,16,19,22-HEXAAZA-CYCLOTETRACOSANE HYDROCHLORIDE
|
126875-56-7 | Silane, (6-ethoxy-3,4-dihydro-2H-pyran-5-yl)trimethyl- (9CI) |
126875-83-0 | Benzenamine, N-(acetyloxy)-4-methyl- |
126876-64-0 | NALTRINDOLE ISOTHIOCYANATE |
126877-05-2 | Acetic acid, 4-(2,6-dihydro-2,6-dioxo-7-phenylbenzo1,2-b:4,5-bdifuran-3-yl)phenoxy-, 2-ethoxyethyl ester |
126877-06-3 | Acetic acid, 4-2,6-dihydro-2,6-dioxo-7-(4-propoxyphenyl)benzo1,2-b:4,5-bdifuran-3-ylphenoxy-, 2-ethoxyethyl ester |
126877-13-2 | Thiazolo[5,4-d]isoxazole (9CI) |
126877-32-5 | 6,8-Methanoisoquinoline(9CI) |
126877-33-6 | 4,7-Methano-1H-pyrrolo[3,4-c]pyridine(9CI) |
126877-68-7 | Isoxazolo[4,5-e]-2,1,3-benzoxadiazole (9CI) |
126878-11-3 | 1H-Pyrrolo[2,3:3,4]pyrazolo[1,5-a]pyrimidine (9CI) |
126878-97-5 | efoxen II |
126879-04-7 | FerrocenylPeg |
126880-72-6 | Cystic Fibrosis Transmembrane Conductance Regulator |
126880-86-2 | L-Selectin |
126881-41-2 | GAMMA-CYCLODEXTRIN SULFATE |
126882-53-9 | [(2R,3R)-4-(3,5-Dimethoxy-4-hydroxyphenyl)-3-(hydroxymethyl)-2-(3,5-dimethoxy-4-hydroxybenzyl)butyl]β-D-xylopyranoside |
126882-55-1 | fasciculic acid B |
126882-56-2 | fasciculic acid C |
126882-76-6 | 3-Methoxy-5-heneicosylphel |
126883-99-6 | Norverapamil N-b-D-Glucuronide |
126889-03-0 | 5-Thiazolecarbonylchloride,4-ethyl-2-methyl-(9CI) |
126889-04-1 | 5-Thiazolecarbonylchloride,2-ethyl-4-methyl-(9CI) |
126889-07-4 | 5-Thiazolecarboxylic acid, 4-ethyl- |
126889-20-1 | iso-atrial natriuretic peptide (23-39) |
126889-55-2 | TRIFLUOROMETHANESULFONIC ACID DIETHYLISOPROPYLSILYL ESTER |
126891-45-0 | 4-BROMOBENZENESULPHONYLACETONITRILE |
126892-00-0 | Benzoxazole, 2-methyl-5-(1-methylethyl)- (9CI) |
126892-32-8 | Ethanone, 1-[(1S,3R)-3-(hydroxymethyl)-2,2-dimethylcyclobutyl]- (9CI) |
126893-36-5 | N N-DIMETHYL-N'-((5-NITRO-2-THIENYL)- |
126893-52-5 | 1,3,5-Cycloheptatriene,3-methoxy-7-(1-methylethyl)-(9CI) |
126893-59-2 | 1,3,5-Cycloheptatriene,1-methoxy-4-(1-methylethyl)-(9CI) |
126895-95-2 | 2-Propenoic acid, 2-methyl-, 2-(dimethylamino)ethyl ester, polymer with butyl 2-propenoate, ethenylbenzene, methyl 2-methyl-2-propenoate and 2-propenoic acid |
126898-32-6 | 4-(5-(5-(4-methyl-1-piperazinyl)-1H-imidazo(4,5-b)pyridin-2-yl)-2-benzoxazolyl)phenol |
126899-49-8 | Spiro[2.4]hepta-4,6-diene-1-carboxaldehyde, 2,2-dimethyl-, (R)- (9CI) |
126901-49-3 | Siloxanes and silicones, 3-(cyclohexylamino) propyl Me, di-Me |
126901-56-2 | Formaldehyde polymer with methyl phenol, 2-hydroxy-3-[(1-oxo-2-propenyl)oxy]propyl ether |
126903-30-8 | fasciclin III |
126903-98-8 | whiG protein |
126904-15-2 | Vamac 123 |
126904-29-8 | contactin |
126906-00-1 | fasciculic acid A |
126909-38-4 | 2-METHOXY-4-METHYL-THIAZOLE-5-CARBOXYLIC ACID |
126909-78-2 | 1-Bromo-3-(cyclopropylmethoxy)benzene |
126909-98-6 | 1H-1,2,4-Triazole,3-(ethylthio)-5-methyl-(9CI) |
126910-31-4 | H-Ala-AFC |
126910-62-1 | 3-(1,1-dimethylethyl)-5-(ethoxycarboxy)-methylthio-1,2,4-triazole |